Regulatory Milestones: How US FDA Guidelines on Single-Enantiomer...

a adăugat un sunet Alte

2026-06-10 12:41:17 -

Regulatory Milestones: How US FDA Guidelines on Single-Enantiomer Drugs Propel Chiral Chemical Demand

In the United States, the demand for high-purity chiral chemicals market is heavily driven by a dominant domestic pharmaceutical market, massive oncology and neurology drug pipelines, and strict FDA guidelines regarding stereoisomeric drugs. Driven by rigorous regulatory frameworks that mandate the thorough evaluation of each enantiomer in a new drug candidate, American chemical formulators...

0 Commentarii 0 Distribuiri 9 Views 0 previzualizare